F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments
Dr. Marty Makary, the agency’s commissioner, said too many women [...]
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the [...]
El ‘médico rural’ que transformó nuestra manera de ver la demencia
Francisco Lopera desafió rebeldes, carteles y murciélagos vampiro para convertirse [...]
Francisco Lopera, the ‘Country Doctor’ Who Upended Our Understanding of Dementia
Francisco Lopera defied rebels, cartels and vampire bats to become [...]
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest [...]
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?
Mientras la FDA estudia otro nuevo medicamento contra el alzhéimer, [...]
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefits
As the F.D.A. considers a new Alzheimer’s medication, we asked [...]
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s
People with two copies of the gene variant APOE4 are [...]
¿Se puede tener alzhéimer y no presentar síntomas?
Una propuesta para cambiar los lineamientos de detección de la [...]
Apparently Healthy, but Diagnosed With Alzheimer’s?
New criteria could lead to a dementia diagnosis on the [...]